Janney Montgomery Scott
PETX

Janney Montgomery Scott’s Aratana Therapeutics, Inc. PETX Stock Holding History

Janney Montgomery Scott’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-15,900
Closed -$84K – 2045
2017
Q4 		$84K Hold
15,900
– – ﹤0.01% 1887
2017
Q3 		$97K Sell
15,900
-500
-3% -$3.16K ﹤0.01% 1783
2017
Q2 		$119K Buy
16,400
+1,200
+8% +$7.38K ﹤0.01% 1688
2017
Q1 		$81K Buy
+15,200
New +$103K ﹤0.01% 1697

Other funds holding PETX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Janney Montgomery Scott's PETX Position: Q1 2018 in Review

Janney Montgomery Scott sold out of Aratana Therapeutics, Inc. (PETX) in Q1 2018, closing a stake of 15,900 shares — an estimated $84K sold.

Janney Montgomery Scott first reported a position in PETX in Q1 2017 and held it in 4 quarters. The position peaked at $119K in Q2 2017. 103 funds tracked by Wall St. Rank hold PETX as of Q1 2018.

  • Janney Montgomery Scott reported no remaining Aratana Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Janney Montgomery Scott sold 15,900 Aratana Therapeutics, Inc. shares in Q1 2018, an estimated $84K.
  • Janney Montgomery Scott first reported a position in Aratana Therapeutics, Inc. in Q1 2017 and held it in 4 quarters.
  • Janney Montgomery Scott's Aratana Therapeutics, Inc. position peaked at $119K in Q2 2017.
  • 103 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q1 2018.

Based on Janney Montgomery Scott's 13F filing for Q1 2018, filed 19 Apr 2018.